Volkswagen in talks to buy stake in EV joint venture partner JAC

By Nikita Chaurasia  Date: 2019-04-11

Volkswagen in talks to buy stake in EV joint venture partner JAC

Apparently, JAC has been in discussions with VW for quite a while now, on extending its collaboration with the German giant on new energy vehicles.

Germany-based automotive conglomerate, Volkswagen AG, has apparently made it to the headlines for having announced that it plan to explore the purchase of a huge stake in JV partner JAC Motors. Authentic reports claim that VW’s move follows the initiatives taken by its fellow rivals Daimler and BMW to strengthen their dominance in the Chinese automotive industry.

As per sources familiar with the knowledge of the matter, VW is now keen to strengthen its ownership in the world’s largest automobile market, post the relaxation of regulations by Beijing last year. With this move, JAC is likely to emerge as one of the most pivotal contenders to help VW in its long-term goal concerning EVs. Indeed, it has been speculated that VW may shift some of its planned EV production in China to JAC in the event that the proposed take acquisition comes to fruition.

According to an official claim by VW, the company has been treading on a cautious path as far as the implications on its business as well as its JV partners are concerned. The statement also affirms that the company plans to explore all the available options with its stakeholders to ensure long-term success in China,

An official statement by VW’s Chinese electric vehicle joint venture partner claims the company to have stated that JAC has been in talks with the German conglomerate for quite a while now, pertaining to the extension of the JV agreement on new energy vehicles. No formal plan has taken shape so far, however, claims an anonymous source.

American investment bank Goldman has apparently been selected by Volkswagen to advise the automotive giant regarding the proposed buyout. Goldman has not publicly commented on VW’s purchase yet.

For the uninitiated, Volkswagen boasts of a market capitalization of almost USD 85 billion, however, the company has no shares in JAC, reported to be valued at USD 1.9 billion.

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

By Nikita Chaurasia

Motorola Solutions has announced to have been selected by Helsetjenestens Driftsorganisasjon for Nødnett HF (HDO HF) to offer the Norwegian Health Emergency Service with a new CRS (Command Central Control Room Solution). Confirming the news,&...

Nestle India exploring options to directly sell products to consumers

Nestle India exploring options to directly sell products to consumers

By Nikita Chaurasia

Nestle India Ltd. is reportedly exploring their options of trying their hands at direct selling since consumers are largely turning towards the internet to purchase products ranging from staples to medicines amidst the COVID-19 pandemic. While the n...

Razorpay: New funding en route, meteoric rise in market value expected

Razorpay: New funding en route, meteoric rise in market value expected

By Nikita Chaurasia

Indian startup Razorpay is reportedly in discussions with Singapore-based sovereign wealth fund GIC Pvt. Ltd. and other existing investors to raise around USD 200 million in a funding round that would allow the fintech company to double its valuation...

FDA to allow pharma companies modify COVID-19 shots amid variants surge

FDA to allow pharma companies modify COVID-19 shots amid variants surge

By Nikita Chaurasia

With the rising cases of Coronavirus variants, the United States Food & Drug Administration (FDA) has reportedly introduced guidelines for pharmaceutical companies to modify their COVID-19 vaccine doses in an effort to curb the spread of the dise...

Gan & Lee partners with IDF to expand its diabetes treatment portfolio

Gan & Lee partners with IDF to expand its diabetes treatment portfolio

By Nikita Chaurasia

China-based leading pharmaceutical organization Gan & Lee Pharmaceuticals Co. Ltd. has announced to have signed a strategic collaboration with the International Diabetes Federation (IDF) to bolster its efforts towards promoting the prevention and...